Literature DB >> 30175322

Uncommon efforts for an uncommon tumor: the case for development of newer systemic therapies for advanced thymic epithelial tumors.

Mohammed Amine Achhal El Kadmiri1, Arun Rajan1.   

Abstract

Entities:  

Year:  2018        PMID： 30175322      PMCID： PMC6117157          DOI： 10.21037/med.2018.03.04

Source DB:  PubMed          Journal:  Mediastinum        ISSN： 2522-6711


× No keyword cloud information.
  17 in total

Review 1.  Chemotherapy for thymic tumors: induction, consolidation, palliation.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Thorac Surg Clin       Date:  2011-02       Impact factor: 1.750

Review 2.  State of the art of genetic alterations in thymic epithelial tumors.

Authors:  Arun Rajan; Nicolas Girard; Alexander Marx
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 3.  The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.

Authors:  Gregory K Pennock; Laura Q M Chow
Journal:  Oncologist       Date:  2015-06-11

4.  Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.

Authors:  Anish Thomas; Yuanbin Chen; Arlene Berman; David S Schrump; Giuseppe Giaccone; Ira Pastan; David J Venzon; David J Liewehr; Seth M Steinberg; Markku Miettinen; Raffit Hassan; Arun Rajan
Journal:  Lung Cancer       Date:  2016-09-28       Impact factor: 5.705

5.  Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.

Authors:  M Kossai; B Duchemann; C Boutros; C Caramella; A Hollebecque; E Angevin; A Gazzah; R Bahleda; E Ileana; C Massard; P Vielh; J C Soria; B Besse
Journal:  Lung Cancer       Date:  2015-06-22       Impact factor: 5.705

Review 6.  Novel Agents in the Treatment of Thymic Malignancies.

Authors:  Claire Merveilleux du Vignaux; Jean-Michel Maury; Nicolas Girard
Journal:  Curr Treat Options Oncol       Date:  2017-08-10

7.  Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

Review 8.  Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

Authors:  J M Michot; C Bigenwald; S Champiat; M Collins; F Carbonnel; S Postel-Vinay; A Berdelou; A Varga; R Bahleda; A Hollebecque; C Massard; A Fuerea; V Ribrag; A Gazzah; J P Armand; N Amellal; E Angevin; N Noel; C Boutros; C Mateus; C Robert; J C Soria; A Marabelle; O Lambotte
Journal:  Eur J Cancer       Date:  2016-01-05       Impact factor: 9.162

9.  The genomic and epigenomic landscape in thymic carcinoma.

Authors:  Motonobu Saito; Yutaka Fujiwara; Tetsuhiko Asao; Takayuki Honda; Yoko Shimada; Yae Kanai; Koji Tsuta; Koji Kono; Shunichi Watanabe; Yuichiro Ohe; Takashi Kohno
Journal:  Carcinogenesis       Date:  2017-10-26       Impact factor: 4.944

10.  Novel biologic therapies for thymic epithelial tumors.

Authors:  Yuanbin Chen; Helen Gharwan; Anish Thomas
Journal:  Front Oncol       Date:  2014-05-07       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.